tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Pasha Sarraf, 3 are a HOLD (37.5%), 5 are a BUY (62.5%).
Analyst Pasha Sarraf, currently employed carries an average stock price target met ratio of 83.33% that have a potential upside of 61.28% achieved within 433 days. Previously, Pasha Sarraf worked at LEERINK.
Pasha Sarraf’s has documented 14 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ACRS, Aclaris Therapeutics at 04-Mar-2021.
Analyst best performing recommendations are on ACRS (ACLARIS THERAPEUTICS).
The best stock recommendation documented was for ACRS (ACLARIS THERAPEUTICS) at 3/4/2021. The price target of $26 was fulfilled within 15 days with a profit of $4.86 (22.99%) receiving and performance score of 15.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$8
$5.28 (194.12%)
1 months 2 days ago
(19-Nov-2024)
0/3 (0%)
$3.83 (91.85%)
Hold
$7
$4.28 (157.35%)
1 months 2 days ago
(19-Nov-2024)
1/5 (20%)
$2.83 (67.87%)
315
Hold
$13
$10.28 (377.94%)
$2
1 months 3 days ago
(18-Nov-2024)
1/5 (20%)
$10.46 (411.81%)
354
Hold
3 months 4 days ago
(17-Sep-2024)
0/5 (0%)
$34.34 (396.54%)
Hold
$1
$-1.72 (-63.24%)
$2
1 years 3 days ago
(18-Dec-2023)
2/4 (50%)
$0.06 (6.38%)
178
What Year was the first public recommendation made by Pasha Sarraf?
